Find a Leader

Applied Filters

Go back to search

Gunars Gaikis

Overview

Gunars Gaikis has more than 25 years’ experience in life sciences intellectual property litigation. He has particularly focused on patent, regulatory and trademark-related litigation for innovative companies in the pharmaceutical and biotechnology areas. He has appeared as lead counsel in many IP cases before the Ontario, Federal and Supreme courts. He is a fellow of the Intellectual Property Institute of Canada, a member of PTMG, and an editorial board member of WIPR Leaders’ sister publication Life Sciences IP Review. He is a frequent speaker at industry events around the world and has had numerous publications on matters related to his practice.

Participation in Wider Community

  • "Clarification of the 'promise' of utility doctrine in Canada," Expert Guides: Patent 2015, March 2015, pp. 88-89
  • "The race for market exclusivity," Life Sciences Intellectual Property Review Quarterly, Vol. 2, Issue 2 (2015)
  • "Cold Feet in Canada," Life Sciences Intellectual Property Review Quarterly, Vol. 2, Issue 1 (2015)
  • "Supreme Court of Canada: VIAGRA patent "void" for insufficient disclosure" (co-authors: J. Sheldon Hamilton and Colin B. Ingram), IP Update — Canada, November 8, 2012
  • "Pharmaceutical Patent Litigation is Inevitable — Typically Overlooked Licensing Terms" (co-authors: Junyi Chen, Jeff J. Kang and Rebecca B. Rodal), presented at the Federated Press conference titled "Negotiating & Drafting Bio Pharma Contracts," June 2011

Professional Affiliations

  • Fellow, Intellectual Property Institute of Canada
  • Member, Pharmaceutical Trade Marks Group
  • Member, American Intellectual Property Law Association
  • Past long-time Chair of the Patent Committee of the IP Section, Canadian Bar Association
  • Editorial board member of LSIPR Newsletter

Academic Affiliations

  • "Navigating Jurisdictional Challenges and Quantifying Damages in s. 8 Cases: Critical Views from Both Sides" panel discussion at the Canadian Institute's 11th Annual Forum on Pharma Patents, Toronto, October 2012
  • "Damages in Patent Infringement and Section 8 Cases: The View from Both Sides" panel discussion at the Canadian Institute's 10th Annual Forum on Pharma Patents, Toronto, October 2011
  • "Strategies in Pharma Patent Litigation," Insight Information's 9th conference on Drug Patents in Canada, Toronto, May 2010
  • "Pharma Patents Litigation: Year in Review," panel discussion at The Canadian Institute's 8th Annual Forum on Pharma Patents, Toronto, October 2009
  • "Pharma Patent Trials Within Two Years," Insight Information's Drug Patent and Legal Forum, Toronto, May 2009

WIPR